NATICK, Mass., Nov. 22, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 25 th Annual Piper Jaffray Healthcare Conference on December 3 in New York.
Mike Mahoney, president and chief executive officer, and Dan Brennan, senior vice president and corporate controller, will participate in a 30-minute question and answer session regarding the company on Tuesday, December 3, at approximately 8:30 a.m. ET.
A live webcast of the question and answer session will be available to interested parties via the Boston Scientific website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
This webcast is being hosted by Piper Jaffray. A replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.About Boston ScientificBoston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook. CONTACT: Denise Kaigler508-650-8330 (office)Global Corporate CommunicationsBoston Scientific Corporation firstname.lastname@example.org Michael Campbell508-650-8023 (office)Investor RelationsBoston Scientific Corporation email@example.com SOURCE Boston Scientific Corporation
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts